OncBioMune Pharmaceuticals, Inc Purchase Agreements

24 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Form of Securities Purchase Agreement dated March 13, 2018
Purchase Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NY
2018
Form of Securities Purchase Agreement
Purchase Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NV
2022
Form of Securities Purchase Agreement for April 2022
Purchase Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NV
2022
Form of Securities Purchase Agreement
Purchase Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NV
2022
Securities Purchase Agreement, dated November 1, 2021
Purchase Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NV
2021
Securities Purchase Agreement, dated July 30, 2021
Purchase Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NV
2021
Securities Purchase Agreement, dated May 12, 2021
Purchase Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NV
2021
Securities Purchase Agreement, dated September 16, 2020, by and among OncBioMune Pharmaceuticals, Inc. and the Investor
Purchase Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NY
2020
Securities Purchase Agreement, dated June 5, 2020, by and among OncBioMune Pharmaceuticals, Inc. Cavalry Fund I LP and Lincoln Park Capital Fund, LLC
Purchase Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NY
2020
Asset Purchase Agreement, dated May 12, 2020, between OncBioMune Pharmaceuticals, Inc. and Avant Diagnostics, Inc
Purchase Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NV
2020
Securities Purchase Agreement dated September 25, 2019
Purchase Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NY
2019
Securities Purchase Agreement
Purchase Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NY
2019
Form of Securities Purchase Agreement
Purchase Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NY
2019
Form of Securities Purchase Agreement
Purchase Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NY
2019
Securities Purchase Agreement between OncBioMune Pharmaceuticals, Inc. and Cavalry Fund I LP, dated March 25, 2019
Purchase Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NY
2019
Securities Purchase Agreement, dated as of January 18, 2019, by and between OncBioMune Pharmaceuticals, Inc. and Cerberus Finance Group Ltd
Purchase Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NY
2019
Securities Purchase Agreement, dated as of January 18, 2019, by and between OncBioMune Pharmaceuticals, Inc. and LG Capital Funding LLC
Purchase Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NY
2019
Securities Purchase Agreement between Cavalry I LP and OncBioMune, Inc., dated November 13, 2018
Purchase Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NY
2018
Securities Purchase Agreement, dated September 24, 2018
Purchase Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NY
2018
Form of Securities Purchase Agreement
Purchase Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NY
2018
Form of Securities Purchase Agreement dated January 29, 2018
Purchase Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NY
2018
Web Site Asset Purchase Agreement dated May 17, 2013 between Lakefield Media Holding AG, Flawsome XLerator GmBH and Pediatrix Inc
Purchase Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NV
2013
Asset Purchase Agreement dated February 21, 2012 with Apricus Biosciences, Inc
Purchase Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
CA
2012
Asset Purchase Agreement dated July 22, 2010 with Cypress Pharmaceuticals, Inc. (portions of the exhibit have been omitted pursuant to a request for confidential treatment)
Purchase Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NV
2010